Longitudinal progression trajectory of GFR among patients with CKD

American Journal of Kidney Diseases

Volumn 59, Issue 4, 2012, Pages 504-512

  Li, Liang ^a   Astor, Brad C ^b   Lewis, Julia ^c   Hu, Bo ^a   Appel, Lawrence J ^d   Lipkowitz, Michael S ^e   Toto, Robert D ^f   Wang, Xuelei ^g   Wright Jr , Jackson T ^g   Greene, Tom H ^h  

^a LERNER RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c VANDERBILT UNIVERSITY   (United States)

^d JOHNS HOPKINS UNIVERSITY   (United States)

^e GEORGETOWN UNIVERSITY   (United States)

^f UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^g CASE WESTERN RESERVE UNIVERSITY   (United States)

^h UNIVERSITY OF UTAH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; ANTIHYPERTENSIVE AGENT; METOPROLOL; RAMIPRIL;

ADULT; AFRICAN AMERICAN; ANTIHYPERTENSIVE THERAPY; ARTICLE; CHRONIC KIDNEY DISEASE; DISEASE COURSE; ETHNIC GROUP; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; KIDNEY FUNCTION; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; OBSERVATIONAL STUDY; PROBABILITY; TREATMENT OUTCOME;

AFRICAN AMERICANS; BAYES THEOREM; CHRONIC DISEASE; COHORT STUDIES; CREATININE; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY DISEASES; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PROTEINURIA; TIME FACTORS;

EID: 84862776975     PISSN: 02726386     EISSN: 15236838     Source Type: Journal    
DOI: 10.1053/j.ajkd.2011.12.009     Document Type: Article

References (16)

1. Mitch W, Walser M, Buffington G, Lemann J. A simple method of estimating progression of chronic renal failure. Lancet. 1976;2(7999):1326-1328.
2. Levey A, Perrone R, Madias N. Serum creatinine and renal function. Ann Rev Med. 1988;39:465-490. (Pubitemid 19090815)
3. Hunsicker LG, Adler S, Caggiula A, et al. Predictors of the progression of renal disease in the Modification of Diet in Renal Disease Study. Kidney Int. 1997;51(6):1908-1919. (Pubitemid 27252762)
4. Klahr S, Levey AS, Beck GJ, et al. The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. N Engl J Med. 1994;330(13):877-884. (Pubitemid 24094966)
5. Lewis EJ, Hunsicker LG, Clarke WR, et al. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med. 2001; 345(12):851-860.
6. Brenner BM, Cooper ME, de Zeeuw D, et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med. 2001;345(12):861-869.
7. Gassman JJ, Greene T, Wright JT Jr, et al. Design and statistical aspects of the African American Study of Kidney Disease and Hypertension (AASK). J Am Soc Nephrol. 2003; 14(7)(suppl 2):S154-S165. (Pubitemid 36750512)
8. Appel LJ, Middleton J, Miller ER III, et al. The rationale and design of the AASK cohort study. J Am Soc Nephrol. 2003; 14(7)(suppl 2):S166-S172. (Pubitemid 36750513)
9. Lewis J, Agodoa L, Cheek D, et al. Comparison of crosssectional renal function measurements in African Americans with hypertensive nephrosclerosis and of primary formulas to estimate glomerular filtration rate. Am J Kidney Dis. 2001;38(4):744-753.
10. Crainiceanu CM, Ruppert D, Wand MP. Bayesian analysis for penalized spline regression using WinBUGS. J Stat Software. 2005; 14(14).
11. Wright JT Jr, Bakris G, Greene T, et al. Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial. JAMA. 2002;288(19):2421-2431. (Pubitemid 35340538)
12. Lindeman RD, Tobin J, Shock NW. Longitudinal studies on the rate of decline in renal function with age. J Am Geriatr Soc. 1985;33(4):278-285. (Pubitemid 15087125)
13. National Kidney Foundation. K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39(2)(suppl 1):S1-S266.
14. R Development Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing; 2011.
15. Norris KC, Greene T, Kopple J, et al. Baseline predictors of renal disease progression in the African American Study of Hypertension and Kidney Disease. J Am Soc Nephrol. 2006;17(10):2928-2936. (Pubitemid 44484684)
16. Hu B, Gadegbeku C, Lipkowitz MS, et al. Kidney function can improve in patients with hypertensive chronic kidney disease: results from the African American Study of Kidney Disease and Hypertension (AASK). J Am Soc Nephrol. In press.